ML P17 2 mg (Doxazosin Mesylate 2 mg)

Pill with imprint ML P17 2 mg is Yellow, Elliptical/Oval and has been identified as Doxazosin Mesylate 2 mg. It is supplied by Dava Pharmaceuticals Inc.

Doxazosin is used in the treatment of raynaud's syndrome; benign prostatic hyperplasia; high blood pressure and belongs to the drug classes alpha-adrenoreceptor antagonists, antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ML P17 2 mg

Doxazosin Mesylate

Imprint: ML P17 2 mg
Strength: 2 mg
Color: Yellow
Size: 10.00 mm
Shape: Elliptical/Oval
Availability: Prescription only
Drug Class: Alpha-adrenoreceptor antagonists, Antiadrenergic agents, peripherally acting
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Dava Pharmaceuticals Inc.
National Drug Code (NDC): 67253-0381 (Discontinued)
Inactive Ingredients: microcrystalline cellulose, sodium starch glycolate type B potato, magnesium stearate, sodium lauryl sulfate, D&C Yellow No. 10, FD&C Yellow No. 6, aluminum oxide, lactose
Note: Inactive ingredients may vary.